Thank god for government R&D grants .... seems to be the only way Starpharma makes a profit these days given the SPL7013 revenues / Receipts from Customers has decreased by almost $400,000 since the June Quarterly but hey tell us all again Cheryl how you were focusing on "Advertising and Marketing" of the SPL7013 products ?
September Quarter $650,000
June Quarterly $1,040,000
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.3¢ |
Change
-0.001(1.06%) |
Mkt cap ! $38.89M | |||
| Open | High | Low | Value | Volume |
| 9.3¢ | 9.3¢ | 9.3¢ | $6.635K | 71.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 120141 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.3¢ | 250000 | 1 |
View Market Depth
| Last trade - 10.38am 16/06/2025 (20 minute delay) ? |
| SPL (ASX) Chart |